StockNews.AI
LH
StockNews.AI
141 days

Labcorp to Announce First Quarter Financial Results on April 29, 2025

1. Labcorp will release Q1 2025 financial results on April 29, 2025. 2. A conference call will discuss these results at 9 a.m. ET. 3. Labcorp performs over 700 million tests annually for global clients. 4. The company supported 75% of new FDA drugs in 2024. 5. Webcast recordings will be available until April 16, 2026.

4m saved
Insight
Article

FAQ

Why Bullish?

Scheduled earnings reports often influence stock prices. Positive market expectations may occur due to Labcorp's strong role in drug approvals.

How important is it?

Earnings reports are crucial for investor decisions, likely affecting stock reactions.

Why Short Term?

Earnings reports deliver immediate market reactions. Results can affect perceptions and stock valuations quickly.

Related Companies

LHRMDABC
, /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2025 before the market opens on Tuesday, April 29, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call. A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until April 16, 2026. To access the webcast recording, visit the Labcorp Investor Relations website. About Labcorp Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at www.labcorp.com. SOURCE Labcorp Holdings Inc WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News